Alphabet's Verily unit is seeking U.S. Environmental Protection Agency approval to release millions of sterilized male mosquitoes in Florida and California [1], [3].

The initiative aims to suppress populations of disease-carrying insects to reduce the transmission of illnesses such as dengue and Zika [1], [2]. By introducing male mosquitoes that cannot produce viable offspring, the company intends to crash the local population of species that spread these viruses [1], [3].

Verily is requesting permission to release up to 32 million Wolbachia-infected mosquitoes [1], [4]. Some reports indicate the figure may be as high as 64 million [2]. The insects are infected with Wolbachia, a naturally occurring bacterium that prevents eggs from hatching when the infected males mate with wild females [2], [5].

This biological control method targets specific mosquito populations without the use of traditional chemical pesticides. The program focuses on the two states due to their susceptibility to tropical disease vectors [3], [5].

The request was filed earlier this month as part of a broader effort by Google's life-sciences division to integrate technology with public health interventions [1], [2]. The EPA must now evaluate the environmental impact and safety of the release before granting the permit [1].

“Alphabet's Verily unit is seeking U.S. Environmental Protection Agency approval to release millions of sterilized male mosquitoes”

This move represents an expansion of 'biocontrol' strategies where technology companies pivot toward ecological engineering to solve public health crises. By utilizing the Wolbachia bacterium, Verily is attempting a scalable alternative to insecticides, which often face regulatory hurdles and environmental criticism. The outcome of the EPA's decision will likely set a precedent for how private tech firms manage biological risks in U.S. urban environments.